A detailed history of Hnp Capital LLC transactions in Dexcom Inc stock. As of the latest transaction made, Hnp Capital LLC holds 13,901 shares of DXCM stock, worth $1.12 Million. This represents 0.45% of its overall portfolio holdings.

Number of Shares
13,901
Previous 14,337 3.04%
Holding current value
$1.12 Million
Previous $1.62 Million 0.49%
% of portfolio
0.45%
Previous 0.46%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 18, 2023

SELL
$104.0 - $122.92 $45,344 - $53,593
-436 Reduced 3.04%
13,901 $1.62 Million
Q4 2022

Jan 24, 2023

SELL
$84.98 - $122.67 $159,762 - $230,619
-1,880 Reduced 11.59%
14,337 $0
Q3 2022

Oct 18, 2022

SELL
$76.35 - $94.18 $9,849 - $12,149
-129 Reduced 0.79%
16,217 $1.31 Million
Q2 2022

Jul 20, 2022

BUY
$67.99 - $132.89 $830,361 - $1.62 Million
12,213 Added 295.5%
16,346 $1.22 Million
Q1 2022

Aug 15, 2022

BUY
$94.08 - $130.2 $388,832 - $538,116
4,133 New
4,133 $2.11 Million
Q1 2022

May 02, 2022

SELL
$94.08 - $130.2 $374,908 - $518,846
-3,985 Closed
0 $0
Q4 2021

Jan 18, 2022

BUY
$129.87 - $162.82 $11,688 - $14,653
90 Added 2.31%
3,985 $2.14 Million
Q3 2021

Oct 14, 2021

BUY
$106.71 - $143.18 $13,018 - $17,467
122 Added 3.23%
3,895 $2.13 Million
Q2 2021

Jul 14, 2021

BUY
$80.99 - $107.93 $15,307 - $20,398
189 Added 5.27%
3,773 $1.61 Million
Q1 2021

May 28, 2021

BUY
$84.79 - $104.74 $30,439 - $37,601
359 Added 11.13%
3,584 $1.29 Million
Q4 2020

Feb 10, 2021

BUY
$78.0 - $104.5 $30,732 - $41,173
394 Added 13.92%
3,225 $1.19 Million
Q3 2020

Nov 09, 2020

BUY
$95.51 - $112.95 $82,425 - $97,475
863 Added 43.85%
2,831 $1.02 Million
Q2 2020

Jul 06, 2020

BUY
$62.68 - $105.34 $123,354 - $207,309
1,968 New
1,968 $802,000

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $31.1B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Hnp Capital LLC Portfolio

Follow Hnp Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hnp Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hnp Capital LLC with notifications on news.